Tag: GlaxoSmithKline

GSK brings legal action against Gilead Sciences

ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline with Pfizer Inc. and Shionogi Ltd., announced that it has filed patent infringement litigation against Gilead Sciences

Avara CDMO bought healthcare facility from GSK

Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK consumer healthcare manufacturing facility

Insilico Medicine and GSK set up a collaboration focused on AI drug discovery

drug discovery
Insilico Medicine announced that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process

GSK closes neuroscience R&D site in China and relocates it to USA

GlaxoSmithKline is closing its neuroscience research and development site in China and is moving it to the company’s hub in the Philadelphia which includes Conshohocken and Collegeville

Exscientia and GSK started drug discovery collaboration

Exscientia, an innovative company at the forefront of Artificial Intelligence-driven drug discovery, announced it has entered into a strategic drug discovery collaboration with GlaxoSmithKline

Teva lost a patent case to GSK and must pay $235 million

A US court yesterday ordered Teva Pharmaceutical Industries Ltd. to pay $235 million compensation to GlaxoSmithKline for violation of the latter's patent

GSK presented results of Benlysta drug study

GlaxoSmithKline announced results from study, which showed that Benlysta (belimumab) plus standard of care prolonged control of disease activity in patients with active systemic lupus erythematosus